ACS
PFE icon

Archford Capital Strategies’s Pfizer PFE Stock Holding History

Archford Capital Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Sell
18,376
-189
-1% -$4.94K 0.04% 262
2026
Q1 		$521K Buy
18,565
+3,603
+24% +$95.9K 0.06% 228
2025
Q4 		$373K Sell
14,962
-1,334
-8% -$33.6K 0.04% 257
2025
Q3 		$415K Sell
16,296
-3,291
-17% -$81.2K 0.05% 240
2025
Q2 		$475K Buy
19,587
+3,886
+25% +$90.6K 0.06% 223
2025
Q1 		$398K Sell
15,701
-731
-4% -$19.1K 0.06% 220
2024
Q4 		$436K Sell
16,432
-583
-3% -$15.8K 0.07% 188
2024
Q3 		$495K Sell
17,015
-2,145
-11% -$62.6K 0.07% 175
2024
Q2 		$536K Sell
19,160
-665
-3% -$18.3K 0.09% 172
2024
Q1 		$550K Buy
19,825
+105
+0.5% +$2.91K 0.09% 169
2023
Q4 		$568K Sell
19,720
-13,871
-41% -$419K 0.1% 159
2023
Q3 		$1.11M Sell
33,591
-613
-2% -$21.7K 0.22% 111
2023
Q2 		$1.28M Sell
34,204
-701
-2% -$27.3K 0.24% 98
2023
Q1 		$1.45M Buy
34,905
+2,730
+8% +$118K 0.3% 78
2022
Q4 		$1.65M Buy
32,175
+2,072
+7% +$99.3K 0.38% 68
2022
Q3 		$1.32M Buy
30,103
+602
+2% +$29.3K 0.34% 75
2022
Q2 		$1.55M Buy
29,501
+2,919
+11% +$149K 0.39% 66
2022
Q1 		$1.36M Buy
26,582
+3,103
+13% +$161K 0.3% 83
2021
Q4 		$1.39M Buy
23,479
+2,336
+11% +$116K 0.32% 83
2021
Q3 		$909K Buy
21,143
+1,191
+6% +$52.8K 0.21% 122
2021
Q2 		$781K Sell
19,952
-399
-2% -$15.5K 0.2% 134
2021
Q1 		$765K Sell
20,351
-22,191
-52% -$788K 0.2% 133
2020
Q4 		$1.58M Sell
42,542
-1,426
-3% -$52.3K 0.36% 84
2020
Q3 		$1.53M Buy
43,968
+1,005
+2% +$35.2K 0.41% 73
2020
Q2 		$1.33M Sell
42,963
-264
-0.6% -$8.97K 0.4% 78
2020
Q1 		$1.34M Sell
43,227
-12,060
-22% -$411K 0.52% 57
2019
Q4 		$2.06M Buy
55,287
+950
+2% +$33.8K 0.71% 42
2019
Q3 		$1.85M Buy
54,337
+3,031
+6% +$110K 0.69% 42
2019
Q2 		$2.11M Sell
51,306
-1,190
-2% -$47.3K 0.77% 31
2019
Q1 		$2.12M Sell
52,496
-1,714
-3% -$68.6K 0.78% 35
2018
Q4 		$2.25M Sell
54,210
-1,305
-2% -$54.2K 0.9% 28
2018
Q3 		$2.32M Sell
55,515
-5,740
-9% -$221K 0.84% 26
2018
Q2 		$2.11M Sell
61,255
-7,843
-11% -$268K 0.74% 31
2018
Q1 		$2.38M Buy
69,098
+162
+0.2% +$5.57K 0.99% 33
2017
Q4 		$2.37M Sell
68,936
-848
-1% -$28.9K 0.88% 35
2017
Q3 		$2.36M Buy
69,784
+2,420
+4% +$77.8K 0.89% 31
2017
Q2 		$2.15M Buy
67,364
+34,138
+103% +$1.08M 0.85% 33
2017
Q1 		$1.08M Sell
33,226
-26,598
-44% -$839K 0.41% 84
2016
Q4 		$1.84M Buy
59,824
+2,377
+4% +$72.6K 0.78% 33
2016
Q3 		$1.85M Buy
57,447
+37,686
+191% +$1.26M 0.76% 34
2016
Q2 		$660K Sell
19,761
-27,134
-58% -$866K 0.35% 93
2016
Q1 		$1.32M Buy
46,895
+43,156
+1,154% +$1.23M 0.63% 48
2015
Q4 		$115K Buy
3,739
+179
+5% +$5.63K 0.05% 200
2015
Q3 		$106K Buy
3,560
+10
+0.3% +$321 0.08% 149
2015
Q2 		$113K Buy
3,550
+10
+0.3% +$326 0.08% 147
2015
Q1 		$117K Buy
3,540
+307
+9% +$9.76K 0.08% 149
2014
Q4 		$96K Buy
3,233
+76
+2% +$2.18K 0.07% 156
2014
Q3 		$89K Sell
3,157
-25
-0.8% -$702 0.07% 161
2014
Q2 		$89.6K Sell
3,182
-670
-17% -$19.1K 0.07% 163
2014
Q1 		$117K Buy
+3,852
New +$115K 0.1% 147

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Archford Capital Strategies's PFE Position: Q2 2026 in Review

Archford Capital Strategies reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $4.94K and leaving 18,376 shares worth $442K. The position accounts for 0.04% of the portfolio, ranked #262.

Archford Capital Strategies first reported a position in PFE in Q1 2014 and has held it in 50 quarters since. The position peaked at $2.38M in Q1 2018. 799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Archford Capital Strategies held 18,376 shares of Pfizer worth $442K as of Q2 2026.
  • Archford Capital Strategies sold 189 Pfizer shares in Q2 2026, an estimated $4.94K.
  • Pfizer made up 0.04% of Archford Capital Strategies's portfolio in Q2 2026, its #262 holding.
  • Archford Capital Strategies first reported a position in Pfizer in Q1 2014 and has held it in 50 quarters since.
  • Archford Capital Strategies's Pfizer position peaked at $2.38M in Q1 2018.
  • 799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.